Evidence map›Paper›PMID 39607522›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024

Exploring facilitators and barriers to daily chlorhexidine gluconate bathing in adult patients undergoing hematopoietic stem cell transplantation.

Ashley L Artese, Michele Sainvil, Laura J Fish, Lauren Hill, Tamara Somers, Anita Matthews, Leah Blazek, Elizabeth Sito, Tessa Andermann, Andrew R Rezvani and 11 more

Abstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Ashley L Artese *Department of Exercise Science and Health Promotion, Florida Atlantic University, 777 Glades Road, Boca Raton, FL, USA. aartese@fau.edu.
Michele Sainvil *Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Laura J FishDepartment of Family Medicine and Community Health, Duke University School of Medicine, Durham, NC, USA.
Lauren HillDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Tamara SomersDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.
Anita MatthewsDuke University Health System Nursing, Durham, NC, USA.
Leah BlazekDuke University Health System Nursing, Durham, NC, USA.
Elizabeth SitoDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Tessa AndermannDivision of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA.
Andrew R RezvaniDivision of Blood & Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA, USA.
Taewoong ChoiDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Cristina J GasparettoDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Mitchell E HorwitzDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Gwynn D LongDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Richard D LopezDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
David A RizzieriNovant Health, Winston Salem, NC, USA.
Stefanie SarantopoulosDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Nelson J ChaoDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Deborah H AllenDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.
Sanghee HongDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Anthony D SungDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.

Funding

TRANSFUSION MEDICINE AND RELATED AREAST32HL007057 · NHLBI · DUKE UNIVERSITY · PI Gowthami M Arepally · 1985 to 2026
$10.6M
BEHAVIOR AND PHYSIOLOGY IN AGINGT32AG000029 · NIA · DUKE UNIVERSITY · PI Maria Marquine · 1985 to 2026
$9.3M
Precision characterization of antimicrobial resistance gene dynamics in bloodstream infection risk after hematopoietic stem cell transplantationK23AI163365 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ANDERMANN, TESSA · 2021 to 2025
$1.0M
Duke Aging Center Postdoctoral Research Training Grant NIA T32 AG000029NHLBI NIH HHS T32 HL007057NIAID NIH HHS K23 AI163365NIA NIH HHS T32 AG000029
6 · The paper itself

Abstract

Hematopoietic cell transplantation (HCT) is a promising treatment for hematologic malignancies, but intensive conditioning leads to immunosuppression and susceptibility to healthcare-associated infections (HAI). Despite standard prevention measures, bloodstream infections (BSI) impact a significant percentage of immunocompromised HCT patients. Incidence of BSI can be mitigated by chlorhexidine gluconate (CHG) bathing-an underutilized infection-prevention strategy. Gaining HCT recipients' perceptions on CHG bathing can inform strategies to improve adherence and enhance patient outcomes. PURPOSE: This study explored patients' perceived facilitators, barriers, and education/knowledge related to CHG bathing and thus addresses the gap in implementation for immunocompromised HCT patients.

methodsThis study used a qualitative description approach to explore patients' perceived facilitators, barriers, and knowledge of CHG bathing. Fourteen HCT recipients (mean 51 ± 16 years) completed semi-structured interviews. Data were analyzed using a rapid qualitative analysis approach to identify themes.

resultsParticipants identified facilitators to using CHG wipes including ease of use, comfort, and staff assistance, along with barriers including wait time, discomfort, and physical challenges. Patient education themes encompassed patient understanding of CHG purpose, perceived ease in learning/application, inconsistent instruction, and inconsistent procedures.

conclusionCHG bathing is a valuable infection prevention strategy for HCT patients. Participants' perspectives highlight the importance of addressing practical challenges and improving education to enhance adherence. This study contributes insights from HCT recipients, emphasizing the need for patient-centered interventions to reduce HAI and improve overall patient care.

Indexed as

Anti-Infective Agents, LocalBathsChlorhexidineHematopoietic Stem Cell TransplantationImmunocompromised HostAdultAgedCross InfectionFemaleHealth Knowledge, Attitudes, PracticeHematologic NeoplasmsHumansMaleMiddle AgedPatient Education as TopicQualitative ResearchAnti-Infective Agents, LocalChlorhexidinechlorhexidine gluconateBarriersChlorhexidine gluconateFacilitatorsHematopoietic stem cell transplantationInfection riskQualitative research

Identifiers

PMID39607522
PMCPMC12090902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.